Diet-induced obesity promotes a myeloma-like condition in vivo

Leukemia

Volumn 29, Issue 2, 2015, Pages 507-510

  Lwin, S T ^a,b   Olechnowicz, S W Z ^a   Fowler, J A ^b   Edwards, C M ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; DICKKOPF 1 PROTEIN; INTERLEUKIN 6; PARAPROTEIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY FAT; BODY MASS; BODY WEIGHT; BONE LESION; BONE MARROW; BONE MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIET INDUCED OBESITY; GENETIC MODEL; LETTER; LIPID DIET; MICRO-COMPUTED TOMOGRAPHY; MONOCLONAL IMMUNOGLOBULINEMIA; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRABECULAR BONE; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ANIMAL; C57BL MOUSE; DISEASE COURSE; DISEASE MODEL; OBESITY; PATHOPHYSIOLOGY;

ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; MICE; MICE, INBRED C57BL; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; OBESITY;

EID: 84922439274     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.295     Document Type: Letter

References (15)

1. Fowler JA, Lwin ST, Drake MT, Edwards JR, Kyle RA, Mundy GR et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood 2011; 118: 5872-5882.
2. Landgren O, Rajkumar SV, Pfeiffer RM, Kyle RA, Katzmann JA, Dispenzieri A et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance (MGUS) among African-American and Caucasian women. Blood 2010; 116: 1056-1059.
3. Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 2011; 47: 1606-1615.
4. Carson KR, Bates ML, Tomasson MH. The skinny on obesity and plasma cell myeloma: a review of the literature. Bone Marrow Transplant 2014; 49: 1009-1015.
5. Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K et al. Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol 2014; 166: 667-676.
6. Hofmann JN, Moore SC, Lim U, Park Y, Baris D, Hollenbeck AR et al. Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study. Am J Epidemiol 2013; 177: 776-786.
7. Murphy F, Kroll ME, Pirie K, Reeves G, Green J, Beral V. Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study. Br J Cancer 2013; 108: 2390-2398.
8. Radl J, Croese JW, Zurcher C, Van den Enden-Vieveen MH, de Leeuw AM. Animal model of human disease. Multiple myeloma. Am J Pathol 1988; 132: 593-597.
9. Fowler JA, Mundy GR, Lwin ST, Edwards CM. Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1. Cancer Res 2012; 72: 2183-2189.
10. Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Hematol Oncol Clin North Am 2007; 21: 1093-1113.
11. Ng AC, Khosla S, Charatcharoenwitthaya N, Kumar SK, Achenbach SJ, Holets MF et al. Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1alpha levels in patients with MGUS. Blood 2011; 118: 6529-6534.
12. Coleman DL, Hummel KP. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 1973; 9: 287-293.
13. Ribeiro AM, Andrade S, Pinho F, Monteiro JD, Costa M, Lopes C et al. Prostate cancer cell proliferation and angiogenesis in different obese mice models. Int J Exp Pathol 2010; 91: 374-386.
14. Georgii-Hemming P, Wiklund HJ, Ljunggren O, Nilsson K. Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. Blood 1996; 88: 2250-2258.
15. Beason TS, Chang SH, Sanfi lippo KM, Luo S, Colditz GA, Vij R et al. Influence of body mass in dex on survival in veterans with multiple myeloma. Oncologist 2013; 18: 1074-1079.